Patents by Inventor Bryan D. Cox

Bryan D. Cox has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiviral agents and nucleoside analogs for treatment of Zika virus
    Patent number: 11963972
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing Zika virus. The compounds include pyrimidine and purine nucleosides and prodrugs thereof, including certain N4-hydroxycytidine nucleoside derivatives, sulfasalazine, and various entry inhibitors.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: April 23, 2024
    Assignee: Emory University
    Inventors: Raymond F. Schinazi, Franck Amblard, Bryan D. Cox, Leda Bassit, Longhu Zhou, Christina Gavegnano
  • Antiviral Agents and Nucleoside Analogs for Treatment of Zika Virus
    Publication number: 20230000893
    Abstract: The present invention is directed to compounds, compositions and methods for treating or preventing Zika virus. The compounds include pyrimidine and purine nucleosides and prodrugs thereof, including certain N4-hydroxycytidine nucleoside derivatives, sulfasalazine, and various entry inhibitors.
    Type: Application
    Filed: March 22, 2017
    Publication date: January 5, 2023
    Inventors: Raymond F. Schinazi, Franck Amblard, Bryan D. Cox, Leda Bassit, Longhu Zhou, Christina Gavegnano
  • Chemokine CXCR4 and CCR5 receptor modulators and uses related thereto
    Patent number: 10450293
    Abstract: The disclosure relates to chemokine receptor modulators and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for managing chemokine related conditions, typically prevention or treatment of viral infections such as HIV or for managing cancer.
    Type: Grant
    Filed: May 15, 2015
    Date of Patent: October 22, 2019
    Assignee: Emory University
    Inventors: Bryan D. Cox, Lawrence J. Wilson, Anthony Prosser, Dennis C. Liotta, James P. Snyder
  • Chemokine CXCR4 and CCR5 Receptor Modulators and Uses Related Thereto
    Publication number: 20170137401
    Abstract: The disclosure relates to chemokine receptor modulators and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions comprising compounds disclosed herein or pharmaceutically acceptable salts or prodrugs thereof. In certain embodiments, the compositions disclosed herein are used for managing chemokine related conditions, typically prevention or treatment of viral infections such as HIV or for managing cancer.
    Type: Application
    Filed: May 15, 2015
    Publication date: May 18, 2017
    Applicant: Emory University
    Inventors: Bryan D. Cox, Lawrence J. Wilson, Anthony Prosser, Dennis C. Liotta, James P. Snyder